We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$72.4B
AUM Growth
+$1.27B
Cap. Flow
+$1.83B
Cap. Flow %
2.53%
Top 10 Hldgs %
13.58%
Holding
3,232
New
150
Increased
2,258
Reduced
427
Closed
137

Top Buys

Rank Stock Value
1
VOYA icon
Voya Financial
VOYA
+$81.9M
2
SPR
Spirit AeroSystems
SPR
+$68.8M
3
GS icon
Goldman Sachs
GS
+$64.1M
4
ABBV icon
AbbVie
ABBV
+$58.2M
5
C icon
Citigroup
C
+$38.6M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$85.8M
2
LO
LORILLARD INC COM STK
LO
+$60.3M
3
MS icon
Morgan Stanley
MS
+$52.6M
4
EXPE icon
Expedia Group
EXPE
+$47.8M
5
CNC icon
Centene
CNC
+$41.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.2%
2 Financials 14.02%
3 Technology 13.59%
4 Industrials 10.74%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARQL
3076
DELISTED
Arqule Inc
ARQL
$34K ﹤0.01%
21,000
FLNA
3077
Filana Therapeutics
FLNA
$48.1M
$33K ﹤0.01%
2,657
-7,972
-75% -$109K
AVEO
3078
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$27K ﹤0.01%
1,510
SPRT
3079
DELISTED
support.com, Inc.
SPRT
$26K ﹤0.01%
6,133
ENZN
3080
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$26K ﹤0.01%
21,300
FRTX
3081
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$25K ﹤0.01%
11
AVNW icon
3082
Aviat Networks
AVNW
$273M
$24K ﹤0.01%
3,146
ONCT
3083
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$24K ﹤0.01%
11
GLBR
3084
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$21K ﹤0.01%
1,408
-15,271
-92% -$271K
ACUR
3085
DELISTED
Acura Pharmaceuticals
ACUR
$21K ﹤0.01%
4,180
PGN
3086
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
$17K ﹤0.01%
15,385
-82,292
-84% -$134K
NOR
3087
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$15K ﹤0.01%
2,357
-17,479
-88% -$280K
GMO
3088
DELISTED
General Moly, Inc.
GMO
$12K ﹤0.01%
15,700
WRES
3089
DELISTED
WARREN RESOURCES INC
WRES
$11K ﹤0.01%
22,100
-116,000
-84% -$99.6K
ACI
3090
DELISTED
ARCH COAL, INC.
ACI
$10K ﹤0.01%
2,650
-148,218
-98% -$1.11M
ADGE
3091
DELISTED
American Dg Energy Inc
ADGE
$5K ﹤0.01%
11,400
WLT
3092
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
$4K ﹤0.01%
15,800
-2,935,467
-99% -$1.35M
AP icon
3093
Ampco-Pittsburgh
AP
$193M
-41,960
Closed -$733K
ASPN icon
3094
Aspen Aerogels
ASPN
$518M
-12,000
Closed -$88K
ATNM icon
3095
Actinium Pharmaceuticals
ATNM
$25M
-970
Closed -$72K
BOOM icon
3096
DMC Global
BOOM
$157M
-30,017
Closed -$384K
CNVS icon
3097
Cineverse
CNVS
$65.6M
-562
Closed -$182K
ERII icon
3098
Energy Recovery
ERII
$443M
-61,300
Closed -$159K
FLWS icon
3099
1-800-Flowers.com
FLWS
$258M
-109,021
Closed -$1.29M
GAIA icon
3100
Gaia
GAIA
$48.4M
-22,000
Closed -$161K

Similar funds

Charles Schwab's Q2 2015 Portfolio in Review

As of Q2 2015, Charles Schwab held 3,232 positions worth $72.4B, up 1.8% from $71.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2015 filing shows 150 new, 2,258 increased, 427 reduced and 137 closed positions. Its largest new stake was Citizens Financial Group: 394,487 shares worth $10.8M. The largest sale was Merck, an estimated $85.8M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Charles Schwab's largest Q2 2015 buy was Citizens Financial Group: 394,487 shares worth $10.8M.
  • Charles Schwab added most to Voya Financial in Q2 2015, an estimated $81.9M increase.
  • Charles Schwab's biggest Q2 2015 reduction was Merck, cutting an estimated $85.8M.
  • Charles Schwab fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $60.3M.
  • Charles Schwab's ten largest holdings make up 14% of its $72.4B portfolio in Q2 2015.
  • Charles Schwab opened 150 new positions and closed 137 in Q2 2015.
  • Charles Schwab's portfolio value rose 1.8% quarter-over-quarter to $72.4B.

Based on Charles Schwab's 13F filing for Q2 2015, filed 14 Aug 2015.